Ensysce Biosciences Secures Commercial Supplier For PF614-MPAR Overdose Protection Drug, Fully Establishing Supply Chain With GMP Nafamostat From Aurore Life Sciences
Ensysce Biosciences Secures Commercial Supplier For PF614-MPAR Overdose Protection Drug, Fully Establishing Supply Chain With GMP Nafamostat From Aurore Life Sciences
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.